. . .
Cell Culture Market
0 0
Read Time:9 Minute, 3 Second

The Cell Culture Market will grow at a CAGR of 11.7% during the forecast period to reach $48.63 billion by 2029, says Meticulous Research®. The cell culture market comprises various consumables and equipment required at different stages of cell culture techniques. Cell culture techniques help in gaining an understanding of basic cell biology & biochemistry. They are model systems and can be used for various applications, such as bioproduction, cancer research, stem cell research, diagnostics, and drug screening. Increasing R&D spending by pharmaceutical & biotechnology companies and funding for cell-based research support studies on chronic diseases and their treatment methods.

The growth in the biopharmaceutical market, the increasing prevalence of chronic diseases, the growing demand for monoclonal antibodies, the increase in research funding, and the rising adoption of single-use technologies are the major factors driving the growth of the cell culture market. Furthermore, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential is expected to provide significant growth opportunities for market stakeholders.

Here are the top 10 companies operating in the Cell Culture Market

Thermo Fisher Scientific Inc. (U.S.)

Thermo Fisher Scientific Inc. (U.S.)Founded in 2006 and headquartered in Massachusetts, U.S., Thermo Fisher Scientific Inc. is a biotechnology company primarily engaged in life sciences research, improving patient diagnostics, and increasing laboratory productivity. The company serves over 400,000 customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research & academic institutions, government firms, and environmental, industrial quality, and process control settings.

The company has four reportable business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes four businesses: Biosciences, Genetic Sciences, Clinical Next-Generation Sequencing, and BioProduction, and cell culture products are offered under the Biosciences subsegment. The Life Sciences Solutions segment caters to the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government sectors.

Thermo Fisher has operations and a presence in approximately 50 countries outside the U.S. The company has major manufacturing and distribution facilities worldwide, including the U.S., Australia, Canada, China, Denmark, Finland, France, Germany, Japan, Singapore, Sweden, and the U.K.


CytivaFounded in 1968 and headquartered in Massachusetts, U.S., Cytiva provides products and services for various applications such as bioprocessing, cell and gene therapy, diagnostics, emerging biotech, enterprise solutions, genomics, lab filtration, and protein research. The products are offered under different brands, including AKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman, and Xcellerex.

Cytiva is a subsidiary of Danaher Corporation. Danaher operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The cell culture products are offered under the Life Sciences business segment through Cytiva.

The company has a strong geographic presence across 40 countries and territories covering Europe, Asia, North America, Latin America, and the Middle East.

Merck KGaA (Germany)

Merck KGaA (Germany)Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a German healthcare and technology company that operates globally through its three major business segments, namely, Life Science, Healthcare, and Electronics. The Life Science business segment is further subsegmented into Research Solutions, Process Solutions and Applied Solutions. The Process Solutions segment offers cell culture products. Research laboratories, pharma and biotech production, and industrial and testing laboratories use products from the Life Science business segment. In 2021, 90 production sites of the company were covered under the ISO 14001 certification.

The Life Science business segment has 52 manufacturing sites and more than 100 distribution centers. Some of its subsidiaries are Merck Life Science BV (Belgium), Merck Millipore Ltd. (Ireland), Merck Life Science S.r.l. (Italy), Sigma-Aldrich Canada Co. (Canada), Sigma-Aldrich Corporation (U.S.), and Merck Life Science Ltd. (China).

HiMedia Laboratories (India)

HiMedia Laboratories (India)Founded in 1982 and headquartered in Mumbai, India, HiMedia Laboratories provides media products and biochemicals for researchers, laboratories, and life sciences industries. These products have various applications in pharmaceutical, agriculture, brewery and fermentation, environmental & sanitary, textile and petroleum, cosmetics, molecular biology, clinical microbiology, water, food, dairy, veterinary, and vaccine production industries. The company has ISO 9001:2015, ISO 13485:2012, and WHO: GMP certifications. It also offers technical product-service packages and custom manufacturing for small-quantity products.

HiMedia has a strong geographic presence in more than 140 countries. It also has its own in-house raw materials manufacturing plant.

Avantor, Inc. (U.S.)

Avantor, Inc. (U.S.)Founded in 1904 and headquartered in Pennsylvania, U.S., Avantor, Inc. manufactures products and provides services for biopharmaceutical, healthcare, education & government, and advanced technologies & applied materials industries. The product and services of the company are categorized into four segments: Third Party Materials & Consumables, Proprietary Materials & Consumables, Equipment & Instrumentation, and Services & Specialty Procurement.

Avantor has more than 200 facilities, including manufacturing, distribution, service, research & technology, and sales centers. It has over 30 global manufacturing facilities, including 16 facilities that are cGMP compliant and 13 facilities that have been registered with the FDA or comparable foreign regulatory authorities. Some of the subsidiaries of the company are Avantor Performance Materials International, LLC (U.S.), VWR International Holdings Pty Ltd (Australia), VWR International China Co., Ltd. (China), VWR International GmBH (Germany), VWR International S.r.l. (Italy), Avantor Performance Materials S.A. de C.V. (Mexico), and Medical Equipment Supplies & Management Ltd. (U.K.).

Meticulous Research in its latest publication on Cell Culture Market  has predicted the growth of 11.7% during the forecast year 2022-2029.

FUJIFILM Holdings Corporation (Japan)

FUJIFILM Holdings CorporationFounded in 1934 and headquartered in Tokyo, Japan, FUJIFILM Holdings Corporation provides products and services for various fields, including medical systems, consumer healthcare, supplement, pharmaceuticals, bio CDMO, regenerative medicine, advanced materials, graphic systems & inkjets, recording media, photo imaging and optical device, and electronic imaging. The company operates through three business segments: Healthcare & Material Solutions, Document Solutions, and Imaging Solutions. The Healthcare & Material Solutions business segment is further subsegmented into Medical Systems, Bio CDMO, and Life Sciences. The Life Sciences segment offers cell culture products.

As of 31st March 2021, the company had 310 consolidated subsidiaries worldwide. The company also has regional management companies in Europe, the U.S., China and Southeast Asia.

Agilent Technologies, Inc. (U.S.)

Agilent Technologies, Inc. (U.S.)Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. is engaged in providing application-focused solutions to the life sciences, diagnostics, and applied chemical markets. The company operates through three business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company offers cell culture products through the Life Sciences and Applied Markets business segment. The Life Sciences and Applied Markets segment focuses on seven markets, namely, pharmaceutical, biopharmaceutical, CRO & CMO, academic and government, chemical & energy, environmental & forensics, and food markets.

Its primary R&D and manufacturing sites are in the U.S. (California, Colorado, Delaware, Massachusetts, Texas, Vermont, and Washington), Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the U.K. As of October 2021, the Life Sciences and applied markets business segment had 5,400 employees.

Sartorius AG (Germany)

Sartorius AG (Germany)Founded in 1870 and headquartered in Gottingen, Germany, Sartorius AG manufactures life science products and services, mainly focusing on the biopharmaceutical industry. The company operates through two business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions portfolio includes cell lines, cell culture media, bioreactors, products for separation, purification and concentration, and products and systems for storing and transporting intermediate and finished biological products. The cell culture products are offered through the company’s subsidiaries: CellGenix GmbH (Germany) and Xell AG (Germany).

The largest product development site for Bioprocess Solutions is present in Göttingen, Germany. The other key activities occur in France, Germany, India, the U.S., the U.K., Sweden, Israel, and Slovenia. Furthermore, its largest production facilities are in Germany, France, and Puerto Rico. Besides these, the company’s manufacturing sites are also present in the U.K., Switzerland, Tunisia, India, the U.S., China, Israel, and Slovenia. Some of the subsidiaries of the company are Sartorius CellGenix GmbH (Germany), CellGenix Inc. (U.S.), Essen BioScience K.K (Japan), and Sartorius Stedim Biotech (Beijing) Co. Ltd. (China)

Corning Incorporated (U.S.)

Corning Incorporated (U.S.)Founded in 1851 and headquartered in New York, U.S., Corning Incorporated offers a wide range of products such as optical communications, mobile consumer electronics, display technology, automotive emissions control, laboratory products, and other glass products. The company operates through five business segments: Display Technologies, Optical Communications, Specialty Materials, Environmental Technologies, and Life Sciences. The Life Sciences products include consumables such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media and serum, general labware, and equipment. These products are used for various applications, including drug discovery research & development, compound screening and toxicology testing, advanced cell culture research, genomics applications, and mass production of cells for clinical trials and bioproduction. The cell culture products are provided under the Cell Culture segment under the primary brands Corning, Falcon, PYREX, and Axygen.

Corning Incorporated has 119 manufacturing plants in 15 countries. The manufacturing units of the Life Sciences business segment are located in California, Illinois, Maine, Massachusetts, New York, North Carolina, Utah, Virginia, China, France, Mexico, and Poland.

Lonza Group Ltd. (Switzerland)

Lonza Group Ltd. (Switzerland)Founded in 1897 and headquartered in Basel, Switzerland, Lonza Group Ltd. provides a wide range of healthcare products and services to the pharmaceutical, biotechnology, and nutrition markets. Its diverse product portfolio includes manufacturing pharmaceutical ingredients and capsules, food supplements, gene therapy and cell media production, and the licensing of technologies and systems. The company operates through four business segments: Biologics, Capsules & Health Ingredients, Small Molecules, and Cell & Gene. The Cell & Gene segment is further categorized into Cell and Gene Technologies and Bioscience divisions. The cell culture products are provided to the academia, biotechnology, and pharmaceutical sectors through the Bioscience division.

The company’s R&D sites are in the U.S., Switzerland, Belgium, Australia, U.K., Germany, the Netherlands, Israel, India, and China. Furthermore, its production sites are present in the U.S., Belgium, France, Germany, Denmark, India, the Netherlands, China, Indonesia, Switzerland, Spain, Mexico, Japan, the U.K., and Singapore. The development and manufacturing sites of the Bioscience division, specifically for cell culture media and culture cells, are present in Walkersville (U.S.), Durham (U.S.), and Verviers (Belgium). Some of its subsidiaries are Lonza USA Inc. (U.S.), Lonza Bioscience Singapore Pte Ltd (Singapore), Lonza Bioscience SARL (France), Capsugel Canada Corp. (Canada), Lonza India Private Limited (India), and Lonza Biologics Ltd. (China).

Authoritative Research on the Cell Culture Market-Global Opportunity Analysis and Industry Forecast (2022-2029)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

  • Recent financial performance
  • Key products
  • Significant company strategies
  • Partnerships and acquisitions

Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.

About Post Author

Meticulous Research

0 %
0 %
0 %
0 %
0 %
0 %

Average Rating

5 Star
4 Star
3 Star
2 Star
1 Star

Leave a Reply

Your email address will not be published. Required fields are marked *